Company to Webcast Presentation on June 10
LEXINGTON, Mass.–(Business Wire)–
Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused
on discovering, developing, and commercializing small molecule drugs to treat
severe medical conditions, today announced that the Company will be presenting
at the Jefferies Global Life Sciences Conference on Thursday, June 10 at 3:30
p.m. (ET) in New York.
A live audio webcast and replay of the presentation will be available on the
“Investors” section of the Company’s website, www.syntapharma.com.
About Synta Pharmaceuticals
Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on
discovering, developing, and commercializing small molecule drugs to extend and
enhance the lives of patients with severe medical conditions, including cancer
and chronic inflammatory diseases. Synta has a unique chemical compound library,
an integrated discovery engine, and a diverse pipeline of clinical- and
preclinical-stage drug candidates with distinct mechanisms of action and novel
chemical structures. All Synta drug candidates were invented by Synta scientists
using our compound library and discovery capabilities. For more information,
please visit www.syntapharma.com.
Synta Pharmaceuticals Corp.
Rob Kloppenburg, 781-541-7125
Copyright Business Wire 2010